INmune Bio saw its stock surge 75% in after-hours trading Thursday after disclosing plans to unveil topline results from its ...

A second phase 3 pivotal clinical trial investigating phentolamine ophthalmic solution 0.75% for the treatment of presbyopia ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...

ST-100 shows promise as a fast-acting treatment for dry eye disease, offering rapid relief and unique collagen repair ...

Thank goodness real science and health experts are working tirelessly to combat the misinformation and disinformation about ...

Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the completion of enrollment in the STORM-PE ...

A phase 3 clinical trial investigating ST-100 for the treatment of dry eye disease did not meet its primary endpoint but ...

A breakthrough clinical trial in Japan reveals that a vitamin B3 derivative significantly improves symptoms of the rare ...

Study met its primary and key secondary endpoints, demonstrating rapid and sustained improvement in near visual acuitySafety ...

Bojungikgi-tang improved anorexia and atopic dermatitis symptoms in a randomized trial, with effects linked to gut microbiome ...

Once-weekly amycretin, a novel peptide activating GLP-1, amylin, and calcitonin receptors, produced rapid, substantial, and ...